Intensified Lipid-Lowering Therapy in Coronary Heart Disease: Is the Concept of "the Lower the Better" Evidence Based?
- PMID: 21086078
- DOI: 10.1007/s11936-010-0101-x
Intensified Lipid-Lowering Therapy in Coronary Heart Disease: Is the Concept of "the Lower the Better" Evidence Based?
Similar articles
-
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].Z Kardiol. 1999 Aug;88(8):582-90. doi: 10.1007/s003920050329. Z Kardiol. 1999. PMID: 10506395 Clinical Trial. German.
-
Intensive lipid-lowering therapy in patients with coronary heart disease.Ann Pharmacother. 2005 Feb;39(2):329-34. doi: 10.1345/aph.1E330. Epub 2004 Dec 21. Ann Pharmacother. 2005. PMID: 15613464 Review.
-
The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.Am J Kidney Dis. 2007 Jan;49(1):37-45. doi: 10.1053/j.ajkd.2006.09.017. Am J Kidney Dis. 2007. PMID: 17185144
-
Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines?Med J Aust. 2001 Nov 5;175(9):471-5. doi: 10.5694/j.1326-5377.2001.tb143679.x. Med J Aust. 2001. PMID: 11758075
-
Lipid-lowering drugs in the management of hyperlipidaemia.Pharmacol Ther. 1998 Sep;79(3):205-30. doi: 10.1016/s0163-7258(98)00018-7. Pharmacol Ther. 1998. PMID: 9776377 Review.
References
LinkOut - more resources
Full Text Sources